CancerDrug

Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation

The Jemperli Royalty Rumble: GSK's Tesaro Unit Takes AnaptysBio to Court

A New Dawn: Why This Lung Cancer Drug Has Scientists (and Patients) Buzzing

The Immortal Foe: Scientists Unravel Cancer's Secret to Eternal Life, Offering a New Dawn in Treatment

A Shot in the Arm for Purple Biotech: Unpacking the Hype Around a Promising Cancer Drug

The Future of Cancer Treatment? CEL-SCI's Multikine Awaits Crucial Saudi Verdict

Cullinan Therapeutics' Breakthrough Cancer Drug Shows Remarkable Efficacy Against Brain Metastases in Lung Cancer Patients

A New Dawn in Lung Cancer Treatment: Gilead and Arcus's Investigational Therapy Shows Promising Survival Advantage

India Greenlights AstraZeneca's Revolutionary Cancer Drug, Offering New Hope to Patients

Global Pharma Giants Set Sights on China: J&J and Roche Reportedly Eyeing Billion-Dollar Cancer Drug Deal with Henlius Biotech

Xilio Therapeutics Soars 8% on Groundbreaking Cancer Drug Data and Strategic Gilead Investment

Cero Therapeutics' Cancer Drug Gets FDA Fast Track, Yet Stock Plummets: Unpacking the Market's Paradox

Glenmark Soars as Pioneering Cancer Drug Envafolimab Enters Crucial Multi-Nation Phase 3 Trial

Groundbreaking Cancer Drug Ivonescimab Propels Akeso Shares After Major Clinical Trial Success

Cancer Breakthrough Ignites HCW Biologics: Stock Soars on Blockbuster Hopes